153 related articles for article (PubMed ID: 19601744)
1. Estrone sulfatase and its inhibitors.
Aidoo-Gyamfi K; Cartledge T; Shah K; Ahmed S
Anticancer Agents Med Chem; 2009 Jul; 9(6):599-612. PubMed ID: 19601744
[TBL] [Abstract][Full Text] [Related]
2. Review of estrone sulfatase and its inhibitors--an important new target against hormone dependent breast cancer.
Ahmed S; Owen CP; James K; Sampson L; Patel CK
Curr Med Chem; 2002 Jan; 9(2):263-73. PubMed ID: 11860358
[TBL] [Abstract][Full Text] [Related]
3. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
4. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
6. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
Geisler J; Sasano H; Chen S; Purohit A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
[TBL] [Abstract][Full Text] [Related]
7. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
8. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
9. Development of potent non-estrogenic estrone sulfatase inhibitors.
Li PK; Chu GH; Guo JP; Peters A; Selcer KW
Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
Billich A; Nussbaumer P; Lehr P
J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
[TBL] [Abstract][Full Text] [Related]
11. Steroidal oxathiazine inhibitors of estrone sulfatase.
Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
[TBL] [Abstract][Full Text] [Related]
12. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
Shah R; Singh J; Singh D; Jaggi AS; Singh N
Eur J Med Chem; 2016 May; 114():170-90. PubMed ID: 26974384
[TBL] [Abstract][Full Text] [Related]
13. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
Stanway SJ; Delavault P; Purohit A; Woo LW; Thurieau C; Potter BV; Reed MJ
Oncologist; 2007 Apr; 12(4):370-4. PubMed ID: 17470679
[TBL] [Abstract][Full Text] [Related]
14. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
15. Steroid sulfatase inhibitors: their potential in the therapy of breast cancer.
Nussbaumer P; Billich A
Curr Med Chem Anticancer Agents; 2005 Sep; 5(5):507-28. PubMed ID: 16178776
[TBL] [Abstract][Full Text] [Related]
16. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
17. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
19. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]